CJC-1295 (No DAC) 10mg

Research indicates that Modified GRF(1-29) can stimulate the release of growth hormone in preclinical and animal research models, producing brief, pulse-like elevations that contrast with the more prolonged activity reported for the DAC-modified version. Studies have investigated its receptor-binding behavior and its role in models of the growth-hormone axis. These reported characteristics have positioned it as a subject of interest in research into pulsatile GH secretion and GHRH-analog pharmacology. Findings to date remain confined to laboratory and animal research contexts.

The safety and toxicological profile of CJC-1295 (No DAC) has not been fully characterized in research models, and comprehensive data remain limited. It is intended strictly for in-vitro and laboratory research and should be handled only by qualified personnel using appropriate personal protective equipment and standard laboratory practices. No conclusions regarding safety in humans or animals can be drawn from current research. Handlers should avoid inhalation, ingestion, and direct contact with skin or eyes.

Recommended ratio

• 1 mL of bacteriostatic water per 10 mg vial
• Equivalent to 10 mg/mL (i.e. 1 mg per 10 units on a 100 U insulin syringe)

1. Remove the plastic flip-off lid from the vial.
2. Disinfect the rubber stoppers with alcohol wipes.
3. Inject the diluent slowly down the inner wall of the vial to avoid foaming.
4. Gently swirl the vial (never shake). Let it dissolve for about 10 minutes.

Unopened / before reconstitution

• Store at a stable temperature.
• Stable for 24 months.
• For long-term storage (2+ years), store at -20 °C.

Reconstituted solution

• Must be kept refrigerated.
• Avoid exposure to light and excessive heat.